ARTICLE | Company News
Silence Therapeutics, AstraZeneca deal
July 26, 2010 7:00 AM UTC
The companies extended by one year to March 11, 2011, a 2007 deal to discover and develop siRNA molecules against up to five undisclosed AstraZeneca targets using Silence's AtuRNAi siRNA technology. T...